The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Open accessAbstract
SUMMARY Reinvigoration of anti-tumor immunity remains an unmet challenge. Our retrospective analyses revealed that cancer patients who took antihistamines during immunotherapy treatment had significantly improved survival. We uncovered that histamine and histamine receptor H1 (HRH1) are frequently increased in the tumor microenvironment and induce T cell dysfunction. Mechanistically, HRH1-activated macrophages polarize toward an M2-like immunosuppressive phenotype with increased expression of the immune checkpoint VISTA, rendering T cells dysfunctional. HRH1 knockout or antihistamine treatment reverted macrophages immunosuppression, revitalized T cell cytotoxic function, and restored immunotherapy response. Allergy, via the histamine-HRH1 axis, facilitated tumor growth and induced immunotherapy resistance in mice and humans. Importantly, cancer patients with low plasma histamine levels had more than tripled objective response rate to anti-PD-1 treatment compared to patients with high plasma histamine. Altogether, pre-existing allergy or high histamine levels in cancer patients can dampen immunotherapy responses and warrant prospectively exploring antihistamines as adjuvant agents for combinatorial immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J. S., Li, B., & Liu, X. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0307 · Cited by 5,913
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0136-1 · Cited by 5,179
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448
A pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063
CellMarker: a manually curated resource of cell markers in human and mouse
Zhang, X., Lan, Y., Xu, J., Quan, F., Zhao, E., Deng, C., Luo, T., Xu, L., Liao, G., Yan, M., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky900 · Cited by 1,524
Self-citationA Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.006 · Cited by 1,429
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Self-citationCyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Zelenay, S., van der Veen, A. G., Böttcher, J. P., Snelgrove, K. J., Rogers, N., Acton, S. E., Chakravarty, P., Girotti, M. R., Marais, R., Quezada, S. A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.015 · Cited by 1,128
Novel Markers to Delineate Murine M1 and M2 Macrophages
Jablonski, K. A., Amici, S. A., Webb, L. M., Ruiz-Rosado, J. D. D., Popovich, P. G., Partida-Sanchez, S., & Guerau-de-Arellano, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145342 · Cited by 978
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y.-H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 966
Self-citationOvercoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
De Henau, O., Rausch, M., Winkler, D., Campesato, L. F., Liu, C., Cymerman, D. H., Budhu, S., Ghosh, A., Pink, M., Tchaicha, J., et al. (2016) · Nature · doi:10.1038/nature20554 · Cited by 860
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Perlman, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0086ma · Cited by 838
Simons, F. E. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra033121 · Cited by 697
Macrophages and cancer: from mechanisms to therapeutic implications
Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 683
Gao, J., Ward, J. F., Pettaway, C. A., Shi, L. Z., Subudhi, S. K., Vence, L. M., Zhao, H., Chen, J., Chen, H., Efstathiou, E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4308 · Cited by 594
Thurmond, R. L., Gelfand, E. W., & Dunford, P. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2465 · Cited by 569
Parsons, M. E., & Ganellin, C. R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706440 · Cited by 556
VISTA is an immune checkpoint molecule for human T cells
Lines, J. L., Pantazi, E., Mak, J., Sempere, L. F., Wang, L., O'Connell, S., Ceeraz, S., Suriawinata, A. A., Yan, S., Ernstoff, M. S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1504 · Cited by 510
VISTA Regulates the Development of Protective Antitumor Immunity
Le Mercier, I., Chen, W., Lines, J. L., Day, M., Li, J., Sergent, P., Noelle, R. J., & Wang, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1506 · Cited by 486
scPred: accurate supervised method for cell-type classification from single-cell RNA-seq data
Alquicira-Hernandez, J., Sathe, A., Ji, H. P., Nguyen, Q., & Powell, J. E. (2019) · Genome Biology · doi:10.1186/s13059-019-1862-5 · Cited by 482
Mouse models of allergic asthma: acute and chronic allergen challenge
Nials, A. T., & Uddin, S. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000323 · Cited by 426
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Mosely, S. I. S., Prime, J. E., Sainson, R. C. A., Koopmann, J.-O., Wang, D. Y. Q., Greenawalt, D. M., Ahdesmaki, M. J., Leyland, R., Mullins, S., Pacelli, L., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0114 · Cited by 415
VISTA is an acidic pH-selective ligand for PSGL-1
Johnston, R. J., Su, L. J., Pinckney, J., Critton, D., Boyer, E., Krishnakumar, A., Corbett, M., Rankin, A. L., Dibella, R., Campbell, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1674-5 · Cited by 402
Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
Liu, J., Yuan, Y., Chen, W., Putra, J., Suriawinata, A. A., Schenk, A. D., Miller, H. E., Guleria, I., Barth, R. J., Huang, Y. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420370112 · Cited by 374
Blando, J., Sharma, A., Higa, M. G., Zhao, H., Vence, L., Yadav, S. S., Kim, J., Sepulveda, A. M., Sharp, M., Maitra, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811067116 · Cited by 334
Self-citationVerma, V., Shrimali, R. K., Ahmad, S., Dai, W., Wang, H., Lu, S., Nandre, R., Gaur, P., Lopez, J., Sade-Feldman, M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0441-y · Cited by 333
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Guerriero, J. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.03.006 · Cited by 293
The “Classical” Ovalbumin Challenge Model of Asthma in Mice
Kumar, R., Herbert, C., & Foster, P. (2008) · Current Drug Targets · doi:10.2174/138945008784533561 · Cited by 254
Elkrief, A., Derosa, L., Kroemer, G., Zitvogel, L., & Routy, B. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz206 · Cited by 246
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.07.001 · Cited by 245
Yang, X. D., Ai, W., Asfaha, S., Bhagat, G., Friedman, R. A., Jin, G., Park, H., Shykind, B., Diacovo, T. G., Falus, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2278 · Cited by 233
Ashina, K., Tsubosaka, Y., Nakamura, T., Omori, K., Kobayashi, K., Hori, M., Ozaki, H., & Murata, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132367 · Cited by 227
Immunoregulatory functions of VISTA
Nowak, E. C., Lines, J. L., Varn, F. S., Deng, J., Sarde, A., Mabaera, R., Kuta, A., Le Mercier, I., Cheng, C., & Noelle, R. J. (2017) · Immunological Reviews · doi:10.1111/imr.12525 · Cited by 197
An overview of the association between allergy and cancer
Turner, M. C., Chen, Y., Krewski, D. R., & Ghadirian, P. (2006) · International Journal of Cancer · doi:10.1002/ijc.21752 · Cited by 156
Histamine receptors and cancer pharmacology: an update
Massari, N. A., Nicoud, M. B., & Medina, V. A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14535 · Cited by 142
TIM-3 Regulates Distinct Functions in Macrophages
Ocaña‐Guzmán, R., Torre-Bouscoulet, L. I., & Sada‐Ovalle, I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00229 · Cited by 122
Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases
Zhang, L., Yao, J., Wei, Y., Zhou, Z., Li, P., Qu, J., Badu-Nkansah, A., Yuan, X., Huang, Y.-W., Fukumura, K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz5387 · Cited by 122
Self-citationTranscriptional profiling identifies novel regulators of macrophage polarization
Gerrick, K. Y., Gerrick, E. R., Gupta, A. K., Wheelan, S. J., Yegnasubramanian, S., & Jaffee, E. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208602 · Cited by 115
Wiktorin, H. G., Nilsson, M. S., Kiffin, R., Sander, F. E., Lenox, B. C., Rydström, A., Hellstrand, K., & Martner, A. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2253-6 · Cited by 91
Histidine Decarboxylase Expression in Human Melanoma
Darvas, Z., Hegyesi, H., László, V., Bencsáth, M., Falus, A., Haak‐Frendscho, M., Kárpáti, S., HOFFMAN, R. L., Szalai, C., Fűrész, J., et al. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00054.x · Cited by 76
Antihistamines as promising drugs in cancer therapy
Faustino‐Rocha, A. I., Ferreira, R. M., Gama, A., Oliveira, P. A., & Ginja, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.12.008 · Cited by 73
Lu, C., Diehl, S. A., Noubade, R., Ledoux, J., Nelson, M. T., Spach, K. M., Zachary, J. F., Blankenhorn, E. P., & Teuscher, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008816107 · Cited by 65
Kugelmann, D., Rotkopf, L. T., Radeva, M. Y., García‐Ponce, A., Walter, E., & Waschke, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-31408-3 · Cited by 64
Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells
Martin, R., Saleem, S. J., Folgosa, L., Zellner, H. B., Damle, S., Nguyen, G.-K. T., Ryan, J. J., Bear, H. D., Irani, A.-M. A., & Conrad, D. H. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a1213-644r · Cited by 60
Relationship between Allergy and Cancer: An Overview
Rittmeyer, D., & Lorentz, A. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000338994 · Cited by 57
Desloratadine and loratadine use associated with improved melanoma survival
Fritz, I., Wagner, P., Bottai, M., Eriksson, H., Ingvar, C., Krakowski, I., Nielsen, K., & Olsson, H. L. (2020) · Allergy · doi:10.1111/all.14273 · Cited by 35
Calcium Around the Golgi Apparatus: Implications for Intracellular Membrane Trafficking
Micaroni, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_18 · Cited by 32
Blood histamine and solid malignant tumors
Moriarty, C. M., Stucky, J. L., Hamburger, K. W., Patil, K. D., Foley, J. F., & Koefoot, R. R. (1988) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00398182 · Cited by 32
The Role of Calcium in Intracellular Trafficking
Micaroni, M. (2010) · Current Molecular Medicine · doi:10.2174/156652410793384204 · Cited by 27
Host response to immune checkpoint inhibitors contributes to tumor aggressiveness
Khononov, I., Jacob, E., Fremder, E., Dahan, N., Harel, M., Raviv, Z., Krastev, B. M., & Shaked, Y. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001996 · Cited by 20
Yao, J., Zhao, Q., Yuan, Y., Zhang, L., Liu, X., Yung, W. K. A., & Weinstein, J. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045894 · Cited by 19
Self-citation
Cited by
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Clinical relevance of tumour-associated macrophages
Pittet, M. J., Michielin, O., & Migliorini, D. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00620-6 · Cited by 731
Wu, M., Huang, Q., Xie, Y., Wu, X., Ma, H., Zhang, Y., & Xia, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01242-2 · Cited by 456
Self-citationSun, C., Wang, A., Zhou, Y., Chen, P., Wang, X., Huang, J., Gao, J., Wang, X., Shu, L., Lu, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38360-5 · Cited by 332
Hwang, M., Canzoniero, J. V., Rosner, S., Zhang, G., White, J. R., Belcaid, Z., Cherry, C., Balan, A., Pereira, G., Curry, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004688 · Cited by 150
Self-citation
Metadata
- Authors
- Li, H., Xiao, Y., Li, Q., Yao, J., Yuan, X., Zhang, Y., Yin, X., Saito, Y., Fan, H., Li, P., Kuo, W.-L., Halpin, A., Gibbons, D. L., Yagita, H., Zhao, Z., Pang, D., Ren, G., Yee, C., Lee, J. J., & Yu, D.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 40
- Issue
- 1
- Pages
- 36-52.e9
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W3215077655
- Cited by
- 286
- References
- 59
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.